Muhammad Mohiuddin, United States Introduction to the session
Prof. Robert A Montgomery, United States Advantages of switching to a Decedent Model
Dr. Alfred J. Tector, United States Advantages of IND enabling NHP studies
Patricia Beaston, United States FDA Perspective